USD 2.13 billion
Report ID:
SQMIG35A2729 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
63
|Figures:
80
Oxygenator Market size was valued at USD 2.13 billion in 2023 and is poised to grow from USD 2.25 billion in 2024 to USD 3.42 billion by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).
The global oxygenator market is a critical component of the healthcare industry, primarily serving patients undergoing surgeries requiring cardiopulmonary bypass and extracorporeal membrane oxygenation (ECMO). This market overview provides insights into the key trends and factors shaping the industry. Oxygenators are medical devices designed to oxygenate and remove carbon dioxide from a patient's blood during surgical procedures or when a patient's lungs or heart are not functioning adequately. They are essential for open-heart surgeries, lung transplants, and the treatment of severe respiratory conditions.
One of the primary drivers of the global oxygenator market is the increasing prevalence of cardiovascular diseases and respiratory disorders. As the global population ages and unhealthy lifestyles become more common, the demand for cardiac surgeries and ECMO procedures rises, leading to a growing need for oxygenators. Technological advancements have significantly improved the efficiency and safety of oxygenators. Miniaturization, biocompatible materials, and improved membrane technology have enhanced their performance while reducing the risk of complications. Additionally, the COVID-19 pandemic brought renewed attention to ECMO as a treatment option for severe respiratory distress, further boosting the market.
Market snapshot - 2025-2032
Global Market Size
USD 2.13 billion
Largest Segment
ECMO Oxygenator
Fastest Growth
ECMO Oxygenator
Growth Rate
5.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Oxygenator Market is segmented by Product Type, Technology, Application, End Use and region. Based on Product Type, the market is segmented into Bubble Oxygenators, Membrane Oxygenators, Low-Flow Oxygenators and High-Flow Oxygenators. Based on Technology, the market is segmented into Mechanical Vented Oxygenators and Non-Invasive Oxygenators. Based on Application, the market is segmented into Cardiopulmonary Bypass, Extracorporeal Membrane Oxygenation (ECMO), Pulmonary Rehabilitation, Neonatal Care, Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Healthcare and Educational and Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In the global oxygenator market, ECMO oxygenators are increasingly dominating the global market. These devices play a critical role in extracorporeal life support systems, assisting patients with severe cardiac or respiratory failure. The dominant position of ECMO oxygenators is attributed to several factors. First, the rising prevalence of heart and lung-related diseases is driving the demand for advanced life support systems. Second, technological advancements in ECMO oxygenators, such as improved membrane materials and enhanced biocompatibility, have increased their effectiveness and safety. Lastly, the COVID-19 pandemic highlighted the importance of ECMO oxygenators in treating severe respiratory distress, further boosting their adoption.
On the other hand, the general oxygenator segment is experiencing rapid growth. General oxygenators are commonly used in cardiac surgery to temporarily replace the function of the heart and lungs during procedures like open-heart surgery. The growth in this segment is fueled by an aging population, increasing prevalence of cardiac diseases, and a growing number of cardiovascular surgeries worldwide. As healthcare infrastructure expands in developing regions, the demand for general oxygenators is expected to rise. Additionally, advancements in general oxygenator design, such as improved oxygenation efficiency and reduced blood trauma, are enhancing their appeal to healthcare providers.
In the global oxygenator market, the respiratory application segment is the dominant. Respiratory oxygenators are widely used in critical care settings, including intensive care units (ICUs), during surgeries, and in emergency medical situations. They are essential for providing life-sustaining oxygenation to patients with compromised respiratory function due to conditions such as acute respiratory distress syndrome (ARDS), pneumonia, or post-surgical recovery. The prevalence of respiratory diseases, coupled with the aging population, has contributed to the dominance of this segment. With the increasing demand for advanced respiratory support systems, respiratory oxygenators continue to be a crucial component in modern healthcare.
On the other hand, the fastest-growing segment in the global oxygenator market is Extracorporeal Cardiopulmonary Resuscitation (ECPR) application segment. ECPR involves the use of oxygenators and extracorporeal membrane oxygenation (ECMO) technology to provide cardiopulmonary support to patients in cardiac arrest or cardiogenic shock. This application has gained traction due to its effectiveness in improving survival rates for patients with severe cardiac and respiratory failure. The growth of ECPR is driven by advancements in technology, increased awareness among healthcare professionals, and the expanding use of ECMO as a rescue therapy in critical care settings. The ability of ECPR to offer extended support to patients in life-threatening situations has positioned it as a rapidly growing segment within the oxygenator market.
To get detailed analysis on other segments, Request For Free Sample Report
The global oxygenator market is analyzed based on its regional presence, which includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America, particularly the United States, plays a dominant role in the global oxygenator market. This dominance can be attributed to several factors, including a well-established healthcare infrastructure, high healthcare expenditure, and a large aging population. Moreover, North America has a robust research and development ecosystem, leading to constant technological advancements and innovations in medical devices like oxygenators. The region also has a high prevalence of cardiovascular diseases and respiratory disorders, which necessitate the use of oxygenators during surgical procedures or as a part of life support systems.
As for the fastest growing segment, Asia-Pacific region, including countries like China, India, and Japan, is one of the fastest-growing markets for oxygenators. The growth in this region is driven by several factors, including the rising healthcare awareness, increasing healthcare investments, and a growing elderly population with chronic diseases. Additionally, improving economic conditions and healthcare infrastructure development in emerging economies have boosted the demand for advanced medical devices like oxygenators. The Asia-Pacific region is also witnessing a surge in medical tourism, leading to increased demand for medical equipment, including oxygenators, for various surgical and treatment procedures.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence of Respiratory Diseases
Aging Population
High Cost of Oxygenator Devices
Stringent Regulatory Requirements
Request Free Customization of this report to help us to meet your business objectives.
The global oxygenator market is highly competitive, with several key players vying for market share. This segment of the medical devices industry provides critical equipment for extracorporeal membrane oxygenation (ECMO) procedures and cardiopulmonary bypass surgeries. Major companies such as Medtronic plc, Terumo Corporation, LivaNova PLC, Getinge AB, and MicroPort Scientific Corporation dominate the market. These players have established themselves through extensive product portfolios, technological advancements, and global distribution networks. Innovation is a key driver in this competitive landscape. Companies are continually investing in research and development to create advanced oxygenator systems that offer improved performance, reduced risk of complications, and enhanced patient outcomes. They also focus on strategic collaborations, partnerships, and acquisitions to expand their market presence and product offerings. Regional players and emerging market entrants often target niche segments or focus on cost-effective solutions to gain a foothold in the market. However, stringent regulatory requirements and the need for quality assurance act as barriers to entry for new players. Overall, the global oxygenator market's competitive landscape is characterized by a mix of established giants, innovative startups, and regional players, with competition driven by innovation, product differentiation, and strategic partnerships.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global oxygenator market analysis, the market is an essential component of the healthcare industry, providing critical support in various medical procedures, particularly during surgeries requiring cardiopulmonary bypass. This analysis provides a succinct overview of key trends and factors influencing the market. The primary driver of the oxygenator market is the increasing prevalence of cardiovascular diseases and the growing number of cardiac surgeries. As the global population ages and lifestyles contribute to heart-related conditions, the demand for oxygenators for use in open-heart surgeries and extracorporeal membrane oxygenation (ECMO) procedures continues to rise. Technological advancements in oxygenator design and materials have improved their efficiency and safety. Miniaturization and biocompatible coatings have made oxygenators more versatile and reduced the risk of adverse reactions during prolonged use. These innovations enhance patient outcomes and expand the potential applications of oxygenators. Furthermore, the COVID-19 pandemic has spotlighted the significance of oxygenators in treating severe respiratory distress cases. ECMO therapy, which employs oxygenators, gained prominence in managing critically ill COVID-19 patients with respiratory failure, contributing to market growth. Despite these drivers, challenges such as high costs associated with oxygenator devices and limited accessibility in developing regions can hinder market expansion. Additionally, the market may face supply chain disruptions and regulatory complexities. In conclusion, the global oxygenator market is expected to experience steady growth due to the increasing prevalence of cardiac diseases, technological advancements, and the expanding application of oxygenators in critical care settings. As healthcare systems strive to enhance patient outcomes, the demand for efficient and advanced oxygenation solutions is likely to remain robust.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.13 billion |
Market size value in 2032 | USD 3.42 billion |
Growth Rate | 5.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Oxygenator Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oxygenator Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oxygenator Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Oxygenator Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Oxygenator Market size was valued at USD 252.25 Million in 2023 and is poised to grow from USD 266.12 Million in 2024 to USD 408.42 Million by 2032, growing at a CAGR of 5.50% during the forecast period (2025-2032).
The global oxygenator market is highly competitive, with several key players vying for market share. This segment of the medical devices industry provides critical equipment for extracorporeal membrane oxygenation (ECMO) procedures and cardiopulmonary bypass surgeries. Major companies such as Medtronic plc, Terumo Corporation, LivaNova PLC, Getinge AB, and MicroPort Scientific Corporation dominate the market. These players have established themselves through extensive product portfolios, technological advancements, and global distribution networks. Innovation is a key driver in this competitive landscape. Companies are continually investing in research and development to create advanced oxygenator systems that offer improved performance, reduced risk of complications, and enhanced patient outcomes. They also focus on strategic collaborations, partnerships, and acquisitions to expand their market presence and product offerings. Regional players and emerging market entrants often target niche segments or focus on cost-effective solutions to gain a foothold in the market. However, stringent regulatory requirements and the need for quality assurance act as barriers to entry for new players. Overall, the global oxygenator market's competitive landscape is characterized by a mix of established giants, innovative startups, and regional players, with competition driven by innovation, product differentiation, and strategic partnerships. 'Medtronic (USA)', 'Sorin Group (Italy)', 'Armstrong Medical (UK)', 'Sarstedt AG & Co. (Germany)', 'O-Two Medical Technologies Inc. (Canada)', 'EWM AG (Germany)', 'Life Support Systems (USA)', 'Terumo Corporation (Japan)', 'HUM Gesellschaft für Homecare und Medizintechnik mbH (Germany)', 'Oxyplus Technologies (France)', 'Teleflex Incorporated (USA)', 'Maquet Holding B.V. & Co. KG (Germany)', 'Rontis Medical (Greece)', 'Armstrong Medical Industries, Inc. (USA)', 'Smiths Medical (USA)', 'Hitec Medical Co., Ltd. (China)', 'Getinge AB (Sweden)', 'Xenia S.r.l. (Italy)', 'Nipro Corporation (Japan)', 'W. L. Gore & Associates, Inc. (USA)', 'XENIOS AG (Germany)', 'LivaNova PLC (UK)', 'Edwards Lifesciences Corporation (USA)', 'MicroPort Scientific Corporation (China)', 'Advancing Life (USA)'
The rising incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), pneumonia, and acute respiratory distress syndrome (ARDS), is a significant driver of the oxygenator market. These conditions often require oxygen therapy, and oxygenators play a crucial role in delivering oxygen to patients, thereby boosting the demand for oxygenator devices.
Technological Advancements: The oxygenator market has been witnessing significant technological advancements. Manufacturers have been investing in research and development to improve the efficiency and performance of oxygenators used in various medical applications, particularly in cardiopulmonary bypass procedures and extracorporeal membrane oxygenation (ECMO). These advancements often include the development of smaller, more portable oxygenators, which can make it easier to manage patients in different healthcare settings.
The global oxygenator market is analyzed based on its regional presence, which includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America, particularly the United States, plays a dominant role in the global oxygenator market. This dominance can be attributed to several factors, including a well-established healthcare infrastructure, high healthcare expenditure, and a large aging population. Moreover, North America has a robust research and development ecosystem, leading to constant technological advancements and innovations in medical devices like oxygenators. The region also has a high prevalence of cardiovascular diseases and respiratory disorders, which necessitate the use of oxygenators during surgical procedures or as a part of life support systems.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2729
[email protected]
USA +1 351-333-4748